伊匹单抗联合福莫司汀治疗转移性黑色素瘤。 - Suppr

Ipilimumab with fotemustine in metastatic melanoma.

作者信息

Garbe Claus

机构信息

Division of Dermatooncology, Department of Dermatology, University Medical Center, 72074 Tuebingen, Germany.

出版信息

Lancet Oncol. 2012 Sep;13(9):851-2. doi: 10.1016/S1470-2045(12)70341-8. Epub 2012 Aug 13.

DOI:10.1016/S1470-2045(12)70341-8

PMID:22894885

Abstract

摘要

相似文献

Ipilimumab with fotemustine in metastatic melanoma.

Lancet Oncol. 2012 Sep;13(9):851-2. doi: 10.1016/S1470-2045(12)70341-8. Epub 2012 Aug 13.

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.

Lancet Oncol. 2012 Sep;13(9):879-86. doi: 10.1016/S1470-2045(12)70324-8. Epub 2012 Aug 13.

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.

Ann Oncol. 2015 Apr;26(4):798-803. doi: 10.1093/annonc/mdu577. Epub 2014 Dec 23.

Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases.

Clin Cancer Res. 2021 Sep 1;27(17):4737-4745. doi: 10.1158/1078-0432.CCR-21-1046. Epub 2021 Jun 10.

[Effectiveness and safety of combined mustoforan, cisplatin and tamoxifen for disseminated cutaneous melanoma (results of the IC4-10036-46-RU trial)].

Vopr Onkol. 2005;51(5):550-7.

Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors.

Clin Cancer Res. 2010 Dec 1;16(23):5862-72. doi: 10.1158/1078-0432.CCR-10-2363. Epub 2010 Oct 28.

Combined treatment of stage IV melanoma patients with amifostine and fotemustine--a pilot study.

Melanoma Res. 1998 Apr;8(2):166-9. doi: 10.1097/00008390-199804000-00011.

Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma.

Melanoma Res. 2000 Oct;10(5):475-82. doi: 10.1097/00008390-200010000-00010.

Fotemustine--an advance in the treatment of metastatic malignant melanoma.

Melanoma Res. 1992 Dec;2(5-6):401-6. doi: 10.1097/00008390-199212000-00015.

Brain metastasis in melanoma: clinical activity of CTLA-4 antibody therapy.

Semin Oncol. 2010 Oct;37(5):468-72. doi: 10.1053/j.seminoncol.2010.09.014.

引用本文的文献

Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas.

Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae199.

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Cell Death Dis. 2023 Jul 26;14(7):468. doi: 10.1038/s41419-023-05955-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Ipilimumab with fotemustine in metastatic melanoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Ipilimumab with fotemustine in metastatic melanoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献